Parker Waichman LLP Comments on First Status Conference in Federal Xarelto Litigation

Share Article

The first status conference in the federal multidistrict litigation over Xarelto's bleeding risks is scheduled for January 29, 2015 in the Eastern District of Louisiana. The Plaintiffs in the litigation allege that the blood thinner may cause uncontrollable bleeding.

News Image
“As a firm that represents numerous individuals who suffered from bleeding complications after taking blood thinners, we are pleased to see this litigation move forward,” said Gary Falkowitz, Managing Attorney at Parker Waichman LLP.

Parker Waichman LLP, a national law firm committed to fighting for victims of defective drugs and medical devices, comments on the first upcoming status conference in the federal multidistrict litigation (MDL) over Xarelto's bleeding risks (In Re: Xarelto Products Liability Litigation, MDL No. 2592). The status conference is scheduled to take place on January 29, 2015 at 9:00 a.m. in the U.S. District Court for the Eastern District of Louisiana, a pretrial order issued in December 2014 shows. Plaintiffs in the litigation allege that Xarelto, an anticoagulant, caused uncontrollable bleeding. Xarelto is prescribed for blood clot prevention and to patients with deep vein thrombosis (DVT) and pulmonary embolism (PE).

According to court documents, the Plaintiffs in the Xarelto MDL also allege that manufacturers Bayer Healthcare and Johnson & Johnson subsidiary, Janssen Pharmaceuticals, failed to adequately warn about the risk of hemorrhaging associated with the drug. It is also alleged that the Defendants wrongfully touted Xarelto as a superior alternative to warfarin, a medication that has been on the market for decades to prevent blood clots. Warfarin requires blood monitoring and dietary restrictions; unlike Xarelto, however, bleeding may be reversed via Vitamin K administration. The risk of uncontrollable bleeding in Xarelto users was highlighted in a MedPage Today article published on April 22, 2014.

“As a firm that represents numerous individuals who suffered from bleeding complications after taking blood thinners, we are pleased to see this litigation move forward,” said Gary Falkowitz, Managing Attorney at Parker Waichman LLP.

Parker Waichman LLP is offering free legal consultations to victims of Xarelto bleeding side effects. If you or a loved one took Xarelto and experienced a life-threatening bleeding event, please contact the firm by visiting our Xarelto Side Effects page at http://www.yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Gary Falkowitz
Follow us on
Visit website